SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-001916
Filing Date
2021-02-19
Accepted
2021-02-19 16:13:28
Documents
4
Period of Report
2021-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm 8-K 35836
2 AT-THE-MARKET ISSUANCE SALES AGREEMENT BY AND BETWEEN ENDRA LIFE SCIENCES INC. A ndra_ex11.htm EX-1.1 261292
3 OPINION OF K&L GATES LLP ndra_ex51.htm EX-5.1 15496
4 IMAGE ndra_ex51000.jpg GRAPHIC 2295
  Complete submission text file 0001654954-21-001916.txt   317159
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 21655718
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences